跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
茁乐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Omalizumab for Injection
Approved
生物制品
Omalizumab for Injection
NOVARTIS EUROPHARM LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Jan 27, 2022
Approval ID
8DqcFdpQhkO
Company
NOVARTIS EUROPHARM LIMITED
Type
生物制品
Approval Details
Approval Id
8DqcFdpQhkO
Approval Number
国药准字SJ20170042
Generic Name
注射用奥马珠单抗
Generic Name En
Omalizumab for Injection
Trade Name
茁乐
Drug Type
生物制品
Dosage Form
注射剂
Strength
150mg/瓶
Reg Date
2022-01-27
Expired Date
2027-01-26
Company Name
NOVARTIS EUROPHARM LIMITED
Production Company Name
Novartis Pharma Stein AG
Company Detail Path
/organization/novartis-europharm-limited
Production Company Detail Path
/organization/novartis-pharma-stein-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 27, 2022
Approval ID
8DqcFdpQhkO
Type
生物制品
Back to NMPA Approvals